Expert Outlook: Sage Therapeutics Through The Eyes Of 14 Analysts
Expert Outlook: Sage Therapeutics Through The Eyes Of 14 Analysts
專家觀點：通過14位分析師的眼睛看sage therapeutics
Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Sage Therapeutics (NASDAQ:SAGE) in the last three months.
在過去的三個月中，14位分析師從看好到看淡提供了多元的觀點，發佈了針對Sage Therapeutics（NASDAQ：SAGE）的評級。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $16.64, with a high estimate of $25.00 and a low estimate of $8.00. This current average has decreased by 18.83% from the previous average price target of $20.50.
分析師對12個月價格目標的評估提供了額外的見解，呈現出一個平均目標爲16.64美元，高估爲25.00美元，低估爲8.00美元。這個目標當前的平均值已經下降了18.83%，比之前的目標價格平均值20.50美元下降了。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
The analysis of recent analyst actions sheds...
最近分析師的行...
登入免費觀看全文
登入/註冊